Akorn, Inc. (AKRX)
-NasdaqGS 14.59 
0.04(0.27%) 24 May 04:00 SGT|After Hours
:
14.59 0.00 (0.00%) 24 May 04:37 SGT
| Prev Close: | 14.55 |
|---|
| Open: | 14.35 |
|---|
| Bid: | 14.57 x 200 |
|---|
| Ask: | 15.68 x 200 |
|---|
| 1y Target Est: | 16.44 |
|---|
| Beta: | 0.14 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 14.33 - 14.62 |
|---|
| 52wk Range: | 11.73 - 16.87 |
|---|
| Volume: | 541,113 |
|---|
| Avg Vol (3m): | 629,752 |
|---|
| Market Cap: | 1.40B |
|---|
| P/E (ttm): | 37.51 |
|---|
| EPS (ttm): | 0.39 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Nasdaq stocks posting largest percentage decreasesAP(Fri, 06:05 SGT)
- AKORN INC FinancialsEDGAR Online Financials(Sat, 18 May)
- AKORN INC Files SEC form 8-K/A, Changes in Registrant's Certifying AccountantEDGAR Online(Tue, 14 May)
- AKORN INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, 10 May)
- Akorn sell-off on Q1 results overdone, says Leerinkat theflyonthewall.com(Wed, 8 May)
- Akorn Hits Estimates in Solid Quarterat Motley Fool(Wed, 8 May)
- Vitamin Shoppe, Fossil, Akorn are big moversAP(Wed, 8 May)
- Vitamin Shoppe, Fossil, Akorn are big moversAP(Wed, 8 May)
- Akorn's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, 8 May)
- Why Akorn Shares Were Crushedat Motley Fool(Wed, 8 May)
Key Statistics
| Forward P/E (1 yr): | 18.47 |
|---|
| P/S (ttm): | 5.02 |
|---|
| Ex-Dividend Date: | 24-May-91 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.55 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.13 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 1.15 |
|---|
Business Summary
Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally.
View More